The SARS-CoV-2 virus, responsible for the covid-19 pandemic, is constantly adapting through mutation. The latest mutations have been identified independently in several countries, indicating a quick evolution of the virus with changes that might help it evade current vaccines.
A Look at the Mutation Process
Mutation refers to a change in the genetic material, or genome, of a cell or virus. Such alterations are usually permanent and can be passed on to descendants. While this genetic material consists of Deoxyribonucleic Acid (DNA) in organisms, viruses may possess either DNA or Ribonucleic Acid (RNA) genomes.
Understanding RNA and DNA Mutations
When cells multiply, errors are sometimes made while copying the DNA into new cells, leading to mutations. However, these errors in DNA virus genomes are often rectified by host cells’ error-correcting function. On the other hand, cells lack enzymes to correct errors in RNA, resulting in RNA viruses such as SARS-CoV-2 accumulating more genetic changes than DNA counterparts.
Significance of Virus Mutation
Mutations play a vital role in virus evolution. Although most mutations are harmful to viruses, some provide selective advantages, like enhanced transmission or infectivity, or the ability to avoid immunity. An advantageous mutation can help a new virus strain outperform its predecessors. The D614G mutation, for instance, increased the coronavirus’s efficiency in infecting and replicating, leading to its prevalence worldwide.
Understanding the RNA Genome of Coronavirus
The SARS-CoV-2 virus possesses unique RNA genomes. With about 30,000 nucleotides, they have the largest genome among RNA viruses. Furthermore, coronaviruses have relatively stable genomes, evolving slower than other RNA viruses like influenza.
Recent Key Mutations in Coronavirus Variants
New variants of the SARS-CoV-2 virus have been identified in several countries. Some feature key mutations in the Spike protein’s Receptor-Binding Domain (RBD). Variants from South Africa and Brazil contain K417N/T, E484K, and N501Y mutations. Meanwhile, the UK variant includes the N501Y and P681H mutations. These RBD mutations could potentially enable the virus to evade antibodies.
Testing Vaccines Against Emerging Variants
Scientists use laboratory tests to evaluate the potential of a new variant to resist antibodies produced by natural infection or vaccination. The serum containing antibodies from recovered or vaccinated individuals is tested to check if the new variant can resist these antibodies.
The Efficacy of Current Vaccines Against Mutations
Reports suggest that existing vaccines like Moderna and Pfizer/BioNTech may offer reduced protection against the South African variant. Both companies are said to be working on new vaccines to combat these mutations. In India, only the UK variant has been detected so far, reportedly among travelers, with no local transmission documented. India’s Covaxin has tested effective against this UK variant according to ICMR-National Institute of Virology and Bharat Biotech scientists.
Necessary Measures and Precautions
As SARS-CoV-2 continues to mutate, implementing preventive measures remains crucial. India, for instance, must maintain mask mandates and crowd limitations while actively tracing the contacts of those infected with the UK variant. Vigilance is also vital towards people who have traveled to mutation-hotspots like South Africa since October 2020 and Brazil since December 2020.
In a proactive move, India has set up the ‘Indian SARS-CoV-2 Genomics Consortium (INSACOG)’ for genomic surveillance. Such surveillance can provide valuable information to track virus transmission and evolution both nationally and internationally. Despite the challenges, these measures alongside continued research form the frontline in the battle against the ever-evolving SARS-CoV-2 virus variants.
Last Modified: February 10, 2024